1Majumdar MK, Keane - Moore M, Buyaner D, et al. Characterization and functionality of cell surface molecules on human mesenchymal stem ceils[ J]. Biomed Sci ,2003,10:228 - 241.
2Han JY, Gob RY, Seo SY, et al. Cotransplantation of cord blood hematopoietic stem cells and culture - expanded and GM - CSF -/SCF- transfeeted mesenchymal stem cells in SCID mice [ J ]. Korean Med Sci ,2007,22:242 - 247.
4Maitra B, Szekely E, Gjini K, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem ceils and suppress T - cell activation[ J]. Bone Marrow Transplant,2004,33:597 - 604.
5Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA - identical sibling culture - expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients [ J]. Biol Blood Marrow Transplant,2005,11 (5) :389 - 398.
7Morad M, Chapel A , Francois S , et al. Homing of in vitro expanded stro - 1 - or stro - 1^ + human mesenchymal stem cells into the NOD/SCID mice and their role in supporting human CD34 cell engraftment [J]. Blood,2004,103(9) :3313 -3319.
9Maitra B, Szekely E, Gjini K, et al. Human mesenchymal stem cell support unrelated donor hematopoietic stem cells and suppress T - cell activation[ J]. Bone Marrow Transplant,2004,33:597 - 604.
3Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999; 284: 143 -151.
4Woodbury D, Schwarz E J, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res,2000; 61:364 -370.
5Hamada T, Mφhle R, Hesselgesser J, et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1( SDF-1 ) enhances platelet formation. J Exp Med, 1998; 188: 539- 548.
6Wang JF, Liu ZY, Groopman JE. The α-chemokine receptor CXCR 4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood, 1998; 92:756 -764.
7Deichmann M, Kronenwett R, Haas R. Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR)and CKR-5 in CD34^+ hematopoietic progenitor cells. Blood, 1997; 89:3522 - 3528.
8Mφhle R, Bautz F, Rafii S, et al. The chemokine receptor CXCR-4is expressed on CD34^+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood, 1998; 91:4523 -4530.
9Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 1996; 382:635 -638.
1Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med,2001 ; 344(3) :175 - 181.
2Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol, 2005;23(22) :5074 - 5087.
3Frangoul H, Nemecek ER, Billheimer D,et al. A prospective study of G-CSF primed bone marrow as a stem-cell source for aUogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood, 2007 ; 110 (13) :4584 -4587.
4Ji SQ, Chen HR, Wang HX, et al. G-CSF-primed haploidentical marrow la'ansplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia. Bone Marrow Trans- plant, 2002; 30(12) :861 -866.
5Lu DP, Dong L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/ haploidentical blood and marrow tansplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood, 2006;107(8) :3065 -3073.
6Xu LP, Liu KY, Liu DH, et al. The inferiority of G-PB to rhG- CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who undcrwent unmani- pulated HLA-mismatched/haploiden-tical transplantation: a comparative analysis. Bone Marrow Transplant, 2010;45(6) :985 -992.
7Isola LM, Scigliano E, Skerrett D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G- CSF. Bone Marrow Transplant, 1997 ;20 (12) :1033 - 1037.
8Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneie bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF- mobilized peripheral blood stem cells. Blood, 2001 ; 98 (12) : 3186 -3191.
10Vasconcelos ZF, Santos BM, Costa ES, et al. T-lymphocyte function from peripheral blood stem ceU donors is inhibited by activated granulocytes. Cytotherapy, 2003 ;5 (4) :336 - 345.
